Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sucampo
Biotech
Aurinia poaches CEO Peter Greenleaf from Cerecor
Peter Greenleaf arrives at Aurinia as it moves its drug, voclosporin, through phase 3 for lupus nephritis.
Amirah Al Idrus
Apr 12, 2019 10:49am
Fledgling biotech Vtesse in $200M buyout from struggling Sucampo
Apr 3, 2017 7:00am
Sucampo 0-2 as it ditches cobiprostone studies after second failure
Jul 11, 2016 9:11am
Sucampo shares slide after its lead experimental drug flunks a PhIIa test
Apr 19, 2016 8:20am
